BYLAWS
of
ALZAMEND NEURO, INC.
A Delaware Corporation
Effective February 25, 2016
ARTICLE I
OFFICES
The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware.
Scientific Advisory Board Charter
of
ALZAMEND NEURO, INC.
A Delaware Corporation
Effective November 2, 2018
I. INTERPRETATION AND OBJECTIVES
This Charter must be interpreted and applied jointly with the other charters and governance policies adopted by the Board of Directors (the “Board”) of Alzamend Neuro, Inc. (the “Company”).
This Charter outlines the purpose, composition and responsibilities of the Scientific Advisory Board (the “Advisory Board”) of the Company.
Audit Committee Charter
of
ALZAMEND NEURO, INC.
A Delaware Corporation
Effective November 2, 2018
The primary responsibility of the Audit Committee (the “Committee”) is to assist the Board of Directors (the “Board”) of Alzamend Neuro™, Inc. (the “Company”) in overseeing management’s conduct of the Company’s financial reporting process. The Committee performs this role by reviewing the financial reports and other financial information released by the Company, the annual independent audit of the Company’s financial statements by the Company’s independent auditors (the “Auditors”), and the Company’s legal compliance
Nomination And Governance Committee Charter
of
ALZAMEND NEURO, INC.
A Delaware Corporation
Effective November 2, 2018
The Nomination and Governance Committee (the “Committee”) is responsible for identifying individuals qualified to become directors and recommending to the Board of Directors (the “Board”) of Alzamend Neuro, Inc. (the “Company”) nominees for the next annual meeting of stockholders. The Committee leads the Board in its annual review of the Board’s performance and recommends to the Board director candidates for each committee for appointment by the Board.
Code Of Ethics and Business Conduct Statement of General Policy
of
ALZAMEND NEURO, INC.
A Delaware Corporation
Effective May 29, 2018
This Code of Ethics and Business Conduct (the “Code”) has been adopted to provide guiding principles to all officers and employees of Alzamend Neuro, Inc.., a Delaware corporation (the “Company”) in the performance of their duties. It also applies in many respects to the directors of the Company. The Code should be read in conjunction with the Company’s other policies that govern employee conduct.
